Other Female Reproductive System O.R. Procedures DRG Reimbursement

DRG 749 encompasses other female reproductive system operative room procedures where a Major Complication or Comorbidity or a Complication or Comorbidity is present; it covers varied gynecologic surgeries with added clinical complexity. Correct assignment of this Diagnosis-Related Group affects inpatient reimbursement under Medicare because the presence of a Major Complication or Comorbidity or a Complication or Comorbidity changes relative weight and payment.

DRG 749 Overview

DRG 749 covers inpatient stays for other female reproductive system operative room procedures when a Major Complication or Comorbidity or a Complication or Comorbidity is present. This Diagnosis-Related Group includes a range of gynecologic surgeries that are not classified under specific organ-system procedure groupings but that involve significant perioperative complexity. It matters for Medicare payment because presence of a Major Complication or Comorbidity or a Complication or Comorbidity increases relative weight and reimbursement compared with stays without these diagnoses. Hospitals and coders must assign procedures and secondary diagnoses accurately to determine appropriate Medicare Severity Diagnosis-Related Group placement and payment.

Trials evaluating perioperative management strategies for complex non-routine gynecologic surgeries (acute intervention focus). These studies compare approaches such as enhanced recovery after surgery (ERAS) protocols, optimized anesthesia techniques, and blood-conservation strategies in patients undergoing other female reproductive system operative procedures with complicating conditions (e.g., significant comorbidities, intraoperative bleeding, or acute infection). Results inform clinicians on reducing complications, length of stay, and resource utilization, which directly affects inpatient costs and DRG-related reimbursement for high-acuity surgical admissions.
Comparative effectiveness studies of surgical techniques and approaches for uncommon reproductive system procedures (procedure-focused comparative study). These trials examine outcomes of different operative methods (for example, minimally invasive versus open approaches or tissue-sparing versus more extensive resections) in patients whose procedures fall into the “other” category and who have CC/MCC-level complexity. Evidence from such studies helps providers choose approaches that optimize clinical outcomes and may influence payer decisions about coverage of techniques that change complication rates, readmissions, or downstream costs tied to this DRG.
Post-discharge outcomes and care coordination research targeting readmission reduction and quality-of-life after complicated gynecologic operations (post-discharge/outcomes study). These studies follow patients discharged after other female reproductive system O.R. procedures with CC/MCC to evaluate interventions such as structured discharge planning, remote monitoring, or targeted rehabilitation to prevent complications and readmissions, and to measure patient-reported outcomes. Findings are relevant to hospitals and payers because they identify strategies to lower costly readmissions, improve recovery metrics, and justify investments in transitional care programs that affect bundled payments and DRG performance.

Trials evaluating perioperative management strategies for complex non-routine gynecologic surgeries (acute intervention focus). These studies compare approaches such as enhanced recovery after surgery (ERAS) protocols, optimized anesthesia techniques, and blood-conservation strategies in patients undergoing other female reproductive system operative procedures with complicating conditions (e.g., significant comorbidities, intraoperative bleeding, or acute infection). Results inform clinicians on reducing complications, length of stay, and resource utilization, which directly affects inpatient costs and DRG-related reimbursement for high-acuity surgical admissions.
Comparative effectiveness studies of surgical techniques and approaches for uncommon reproductive system procedures (procedure-focused comparative study). These trials examine outcomes of different operative methods (for example, minimally invasive versus open approaches or tissue-sparing versus more extensive resections) in patients whose procedures fall into the “other” category and who have CC/MCC-level complexity. Evidence from such studies helps providers choose approaches that optimize clinical outcomes and may influence payer decisions about coverage of techniques that change complication rates, readmissions, or downstream costs tied to this DRG.
Post-discharge outcomes and care coordination research targeting readmission reduction and quality-of-life after complicated gynecologic operations (post-discharge/outcomes study). These studies follow patients discharged after other female reproductive system O.R. procedures with CC/MCC to evaluate interventions such as structured discharge planning, remote monitoring, or targeted rehabilitation to prevent complications and readmissions, and to measure patient-reported outcomes. Findings are relevant to hospitals and payers because they identify strategies to lower costly readmissions, improve recovery metrics, and justify investments in transitional care programs that affect bundled payments and DRG performance.

OpenPayer

Summary & Overview

Other Female Reproductive System O.R. Procedures with CC/MCC: Inpatient Reimbursement Overview

DRG 749 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes